At a glance
ClinicalIndex Comparison RecordN/ACompleted· 146 enrolled
Drug / intervention
Zemedy App for Irritable Bowel Syndromebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Acceptability and Efficacy of the Zemedy App for Irritable Bowel Syndrome
In Brief
A clinical study evaluating Zemedy App for Irritable Bowel Syndrome for Irritable Bowel Syndrome. Completed, enrolled 146 participants across 1 site.
Detailed Summary
The purpose of this research is to assess if a new self-help app for IBS is an acceptable and effective intervention for improving the overall quality of life in patients with Irritable Bowel Syndrome.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIrritable Bowel Syndrome
CountriesUnited States
CollaboratorsBold Health Inc.
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartOct 2019
First PostedNov 2019
Primary CompletionSep 2020
TodayJul 2026
First PostedNov 20, 2019
Enrollment StartOct 28, 2019
Primary CompletionSep 28, 2020
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 6.6 years ago
Interventions
Zemedy App for Irritable Bowel Syndromebehavioral
The Zemedy App for irritable bowel syndrome is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.